[1]
Aydin, M., Ergin, E., Tuncel, E.T., Dirik, Y., Ozluk, S., Guducuoglu, H. and Dulger, A.C. 2021. Effectiveness and safety of orally administered silymarin (milk thistle) for pegylated interferon unresponsive chronic delta hepatitis patients: Silymarin treatment for pegylated interferon unresponsive chronic delta hepatitis. Medical Science and Discovery. 8, 7 (Jul. 2021), 428–431. DOI:https://doi.org/10.36472/msd.v8i7.577.